Optimizing anti-TNF therapy in Behçet’s disease: the role of therapeutic drug monitoring

Marko Barešić, Ljiljana Smiljanić Tomičević, Ana Kozmar, Miroslav Mayer

Open source

DOI: 10.3389/fimmu.2026.1930666
Published: 2026-08-03
Container: Frontiers in Immunology
Publisher: Frontiers Media SA
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2026.1930666,
  title = {Optimizing anti-TNF therapy in Behçet’s disease: the role of therapeutic drug monitoring},
  author = {Marko Barešić and Ljiljana Smiljanić Tomičević and Ana Kozmar and Miroslav Mayer},
  year = {2026},
  journal = {Frontiers in Immunology},
  doi = {10.3389/fimmu.2026.1930666},
  url = {https://doi.org/10.3389/fimmu.2026.1930666}
}

RIS

TY  - JOUR
TI  - Optimizing anti-TNF therapy in Behçet’s disease: the role of therapeutic drug monitoring
AU  - Marko Barešić
AU  - Ljiljana Smiljanić Tomičević
AU  - Ana Kozmar
AU  - Miroslav Mayer
PY  - 2026
JO  - Frontiers in Immunology
DO  - 10.3389/fimmu.2026.1930666
UR  - https://doi.org/10.3389/fimmu.2026.1930666
ER  -

APA

Barešić, M., Tomičević, L. S., Kozmar, A., & Mayer, M. (2026). Optimizing anti-TNF therapy in Behçet’s disease: the role of therapeutic drug monitoring. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2026.1930666

Source records

crossref · retrieved 2026-09-26T04:19:28.503Z